Ngo-2025, i-Tirzepatide ikhula ngokushesha emkhakheni wokwelapha izifo ze-metabolic emhlabeni wonke. Njengoba ukukhuluphala nesifo sikashukela kuqhubeka ukwanda, futhi kukhulisa ukuqwashisa komphakathi ngokuphathwa okuphelele kwe-metabolic, le nhlangano emisha ye-GLP-1 ne-GIP agonist ikhulisa ngokushesha imakethe yayo.
U-Eli Lilly, nemikhiqizo yakhe i-Mounjaro ne-Zepbound, ubambe isikhundla esiphezulu emhlabeni jikelele. Isekelwa ubufakazi obuqinile bomtholampilo, ukusebenza kahle kwe-Tirzepatide ekulawuleni i-glycemic, ukuncipha kwesisindo, nokuvikelwa kwenhliziyo kuye kwaqinisekiswa ngokwengeziwe. Idatha yakamuva yomtholampilo yango-2025 ikhombisa ukuthi i-Tirzepatide idlula izidakamizwa ezifanayo ekwehliseni ubungozi bomcimbi wenhliziyo nemithambo yegazi, ngokuncipha kokushona kwamadijithi amabili. Lokhu kuphumelela akukhulisi nje kuphela ukuzethemba kukadokotela kodwa futhi kuqinisa icala lezingxoxo ezivumayo zokubuyisela imali.
Ukuthuthukiswa kwenqubomgomo nakho kufaka umfutho ekukhuleni kwezimakethe. Uhulumeni wase-US umemezele izinhlelo zokufaka izidakamizwa ezinciphisa isisindo, kuhlanganise ne-Tirzepatide, ngaphansi kokufakwa kwe-Medicare kanye ne-Medicaid kusukela ngo-2026. Lokhu kuzokwandisa kakhulu ukufinyelela kwesiguli, ikakhulukazi phakathi kwabantu abangabizi kakhulu, ukusheshisa ukungena emakethe. Ngaleso sikhathi, isifunda sase-Asia-Pacific sivela njengemakethe ekhula ngokushesha ngenxa yezinguquko zokunakekelwa kwezempilo, ukufakwa komshwalense okubanzi, kanye nenani elikhulu labantu.
Nokho, izinselele zisekhona. Intengo ephezulu ye-Tirzepatide—ngokuvamile eyeqa u-$1,000 ngenyanga—iyaqhubeka nokukhawulela ukutholwa okusabalele lapho umshuwalense unganele. Imikhawulo yangemva kokushoda kwe-FDA kumajenerikhi ahlanganisiwe inyuse izindleko kwezinye iziguli, okuholele ekuyekisweni kokwelashwa. Ngaphezu kwalokho, imiphumela emibi evamile yokugaya ukudla ehlobene nezidakamizwa ze-GLP-1, kanye nokukhathazeka okungokomthetho eziteshini zokuthengisa eziku-inthanethi, kudinga ukunakwa okuqhubekayo kuzo zombili izimboni nabalawuli.
Uma ubheka phambili, amandla okukhula kwemakethe ye-Tirzepatide ahlala eqinile. Ngokunwetshwa okwengeziwe kwezinkomba (isb., ukuphelelwa umoya okuphazamisayo, ukuvimbela izifo zenhliziyo), ukumbozwa komshwalense okujulile, kanye nokwamukelwa kwamathuluzi okuphatha ukwelashwa kwedijithali nezinhlelo zokweseka iziguli, isabelo sikaTirzepatide emakethe yezidakamizwa zomhlaba wonke kulindeleke ukuthi sikhule kancane kancane. Kubadlali bezimboni, ukusizakala ngezinzuzo zomtholampilo, ukuthuthukisa amamodeli okukhokha, kanye nokuthola ukutholakala kusenesikhathi ezimakethe ezisafufusa kuzoba ukhiye ekuwineni umqhudelwano wesikhathi esizayo.
Isikhathi sokuthumela: Aug-05-2025